Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

DR. AGARWAL'S HEALTH CARE LTD.

NSE : AGARWALEYEBSE : 544350ISIN CODE : INE943P01029Industry : Hospital & Healthcare ServicesHouse : Private

BSE547.104.35 (+0.8 %)

PREV CLOSE ( ) 542.75

OPEN PRICE ( ) 544.65

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 26353

TODAY'S LOW / HIGH ( )535.70 553.00

52 WK LOW / HIGH ( )327.4 567.8

NSE545.704.2 (+0.78 %)

PREV CLOSE( ) 541.50

OPEN PRICE ( ) 541.50

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 545.70 (980)

VOLUME 507732

TODAY'S LOW / HIGH( ) 535.95 553.65

52 WK LOW / HIGH ( )327 568

Select year

(Rs.in Million)

Particulars

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Profit Before Tax

1598.50

1405.70

835.91

567.63

-483.51

Adjustment

3315.00

2328.70

1974.03

1381.72

1452.33

Changes In working Capital

-944.20

46.40

-125.05

-150.11

97.72

Cash Flow after changes in Working Capital

3969.30

3780.80

2684.89

1799.24

1066.54

Cash Flow from Operating Activities

3603.30

3460.00

2331.06

1643.28

991.59

Cash Flow from Investing Activities

-7503.30

-9139.10

-5090.85

-1553.51

-365.69

Cash Flow from Financing Activities

3818.60

5526.80

3033.39

354.33

-371.07

Net Cash Inflow / Outflow

-81.40

-152.30

273.60

444.10

254.83

Opening Cash & Cash Equivalents

1117.50

1269.80

996.21

552.11

386.57

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

-89.27

Closing Cash & Cash Equivalent

1036.10

1117.50

1269.81

996.21

552.12